{"rewrite":{"id":"r_239c22fd490ae487d9a65043","clusterId":"c_6bc276fb35875cb652c754f4","slug":"anthropic-cuts-claude-fable-5-biology-fallbacks-by-about-85","model":"deepseek-v4-flash:free","headline":"Anthropic Cuts Claude Fable 5 Biology Fallbacks by About 85%","summary":"Anthropic updated the biology safety measures for Claude Fable 5, reducing false restrictions on low-risk questions. The company rewrote classification rules, updated training data, and retrained the safety classifier. As a result, biology-related fallbacks to Claude Opus 5 decreased by about 85%, making the model easier to use for everyday health consultations and biology learning.","whyItMatters":"The update narrows the broad safety margin set at Fable 5's launch, cutting false positives while keeping dual-use topics like virology and toxicology routed to the lower-capability Opus 5.","webCardHtml":"\u003cp\u003eAnthropic has loosened the biology guardrails on Claude Fable 5 after its initial launch settings proved too cautious. The company said the previous measures flagged even harmless questions about test results or general biology study, because the priority was not missing dangerous requests.\u003c/p\u003e\u003cp\u003eThe revised system rewrites the classification rules, refreshes the training data, and retrains the safety classifier. In tests, the rate at which biology questions were switched to Claude Opus 5 dropped by about 85 percent.\u003c/p\u003e\u003cp\u003eSpecialized dual-use areas, including virology, toxicology, and molecular design, still route to Opus 5. Anthropic said it will keep working to reduce false detections and build mechanisms for researchers to use Fable 5\u0026#39;s biology capabilities safely.\u003c/p\u003e","blueskyPost":"Anthropic's 85% fallback cut shows the safety classifier was over-triggering on routine biology queries. The retraining targets false positives, not the underlying policy.","twitterPost":"Anthropic's 85% fallback reduction targets false positives, not policy. The classifier now distinguishes low-risk biology questions from sensitive ones.","threadsPost":"Anthropic's 85% fallback reduction is a classifier fix, not a policy change. Rewrote rules, updated training data, retrained the model. The result: fewer low-risk biology questions get bumped to Claude Opus 5, making it more usable for health consultations and learning.","newsletterBlurb":"Anthropic revised Claude Fable 5's biology safety measures, cutting false restrictions on harmless questions. Biology-related fallbacks to Claude Opus 5 fell about 85%, while dual-use topics like virology and toxicology still route to the lower-capability model.","attributionJson":"[{\"source\":\"GIGAZINE\",\"url\":\"https://gigazine.net/news/20260810-claude-fable-5-biology-safeguard/\",\"title\":\"Claude Fable 5 Improves Issue of Overly Restrictive Biology Questions, Reduces False Detections and Cuts 'Fallback' by About 85%\"}]","lintFlagsJson":null,"lintHits":0,"costUsd":0,"inputTokens":4646,"outputTokens":591,"status":"published","repairAttempts":0,"nextRepairAt":null,"factsAttemptedAt":1786426441,"createdAt":"2026-08-11T05:25:18.000Z","publishedAt":"2026-08-11T05:26:44.000Z","updatedAt":"2026-08-11T05:25:18.000Z"},"cluster":{"id":"c_6bc276fb35875cb652c754f4","canonicalTitle":"Claude Fable 5で生物学の質問が過剰に制限される問題を改善、誤検出を減らして「フォールバック」を約85％削減","representativeArticleId":"a_c68a2a6a130e6d996bc757eb","sourceCount":1,"writtenSourceCount":1,"writeAttempts":0,"isSolo":true,"entitiesJson":"{\"anime_titles\":[],\"manga_titles\":[],\"work_titles\":[],\"studios\":[],\"people\":[],\"type\":\"news\",\"domain\":\"other\",\"is_roundup\":false}","contentType":"news","status":"published","firstSeenAt":"2026-08-10T11:50:00.000Z","lastSeenAt":"2026-08-10T11:50:00.000Z","updatedAt":"2026-08-11T05:26:44.000Z"},"attribution":[{"source":"GIGAZINE","url":"https://gigazine.net/news/20260810-claude-fable-5-biology-safeguard/","title":"Claude Fable 5で生物学の質問が過剰に制限される問題を改善、誤検出を減らして「フォールバック」を約85％削減"}],"entities":{"anime_titles":[],"manga_titles":[],"work_titles":[],"studios":[],"people":[],"type":"news","domain":"other","is_roundup":false},"keyFacts":null}
